Adipose tissue is not only a reservoir for energy, but also an immune organ. In the context of obesity, the development of insulin resistance is now recognised to be initiated by inflammation of the adipose tissue. However, the primary events triggering this inflammation are still unclear, as a complex combination of endocrine and immune factors act to regulate this adipose tissue microenvironment. Below we discuss the different factors involved and how they affect the biology of the adipose tissue in obesity.
Introduction
Despite general awareness that obesity is a global health problem, and the many programs established to tackle this epidemic, one-third of the world's adult population are either overweight or obese, and children are becoming obese at younger age [1] . This poses a major public health issue as obesity and overweight increase the risk of serious chronic illness including type 2 diabetes, hypertension, cardiovascular diseases, asthma and certain forms of cancer [2] . In addition to its roles in energy storage and as an endocrine organ, adipose tissue is increasingly recognised as an important immune organ. Obesity is now accepted as a low grade, chronic inflammatory disease that is linked to metabolic disorders, including type 2 diabetes and insulin resistance [3] . Understanding the relationship between the endocrine and immune functions of the adipose tissue may have important implications for the development of new therapeutic strategies for obesity and associated disease.
Metabolic regulation of adipose tissue
Adipose tissue is known to secrete a large number of proteins which regulate metabolism, energy intake and fat storage. Over 50 adipokines have been identified; they have diverse roles, but there is compelling evidence for the effects of leptin, adiponectin, interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-a) on adipocyte metabolism and insulin sensitivity, and thus for their roles in obesity and associated metabolic disorders.
Leptin
Leptin was the first adipocyte hormone identified through its role in the regulation of food intake [4] . Its acts directly on the hypothalamus and on other regions of the brain to reduce food intake [5] , and mutations affecting the genes coding for leptin or its receptor are linked with morbid obesity [6] , demonstrating its critical physiological role. In obesity, circulating concentrations of leptin rise and the cells it targets became resistant to its effects [7] ; this leptin resistance is thought to play a part in the development and maintenance of obesity. Besides its actions on the central nervous system, leptin also plays a role in the regulation of the immune response as an inflammatory molecule capable of activating adaptive immune cells in different nutritional states [8, 9] .
Adiponectin
Another major adipokine affecting metabolism is adiponectin. This hormone enhances insulin sensitivity by increasing fatty acid oxidation and reducing glucose production in the liver [10] . In contrast to leptin, plasma adiponectin levels are decreased in the obese, suggesting a physiological role in insulin sensitivity, and in accord with this, polymorphisms in the adiponectin gene resulting in decreased circulating adiponectin are associated with risk of type 2 diabetes, insulin resistance and the metabolic syndrome [11] . Like leptin, adiponectin has been shown to affect the immune response, suppressing M1 macrophage activation and promoting M2 macrophage proliferation, and therefore reducing the proinflammatory environment of the adipose tissue [12] .
IL-6
In addition to adipokines, the adipose tissue also secretes cytokines that can affect energy metabolism. IL-6 has pro-inflammatory and anti-inflammatory properties, and has been shown to increase insulin resistance by inhibiting lipoprotein lipase (LPL). As LPL is responsible for the hydrolysis of triglycerides into free fatty acids [13] , a reduction in LPL activity leads to greater fat cell size as their storage of triglyceride is increased. However, counter-intuitively, mice lacking IL-6 develop glucose intolerance and insulin resistance [14] , which may reflect over expression of other cytokines and adipokines in response to hepatic inflammation.
TNF-a
Another major cytokine involved in adipocyte metabolism is TNF-a. Adipose tissue expression of TNF-a is increased in obese patients and, like IL-6, TNF-a participates in the development of insulin resistance by inhibiting LPL and thus glucose uptake by the adipocytes [15] . Moreover, TNF-a inhibits the conversion of preadipocytes to mature adipocytes during the expansion of adipose tissue mass [16] .
Adipose tissue as an immune organ
The adipose tissue contains a large diversity of immune cells that make it an immune organ capable of linking metabolism and immunity. The metabolic and immune function of adipocytes and stromal vascular fraction of adipose tissue (containing preadipocytes, endothelial and immune cells) are tightly linked, and their 'microenvironment' is fragile and easily disrupted.
Immune cells and adipose tissue
Before the consideration of the adipose tissue as an immune organ and obesity as a low-grade inflammatory state, the development of insulin resistance in obesity was described as the result of the hypertrophy of adipocytes and the increase in pro-inflammatory adipokines like TNF-a and IL-6; the infiltration of immune cells was not recognised as participating in the process. However, 15 years ago, the infiltration and accumulation of macrophages in adipose tissue was demonstrated to be associated with the increased TNF-a and IL-6 secretion, contributing to insulin resistance [17] . Moreover, subsequent studies have highlighted the complexity of the mechanisms involved, demonstrating that obesity results in the recruitment of circulating pro-inflammatory macrophages (M1 macrophages) and the switching of resident M2 macrophages to M1 type macrophages [18, 19 ] . A recent study emphasizes the multiplicity of regulatory mechanisms involved as a high fat diet (HFD) induces inflammasome activation in colonic macrophages prior to their recruitment in the adipose tissue [20] . The role of autophagy in macrophages also seems to play an important role in regulating systemic insulin sensitivity and glucose tolerance [21 ] . Thus, macrophages are not only involved in inflammatory processes in the adipose tissue, but also in the regulation of fat metabolism.
Activation of the adaptive immune system is now considered the primary event of adipose tissue inflammation. It occurs before the hypertrophy of the adipocytes and has been shown to play a major role in the recruitment and activation of macrophages. Infiltration of CD4 + T cells into the adipose tissue coincides with the early stages of insulin resistance in obesity [22] . CD4 + T cells are activated directly by adipocytes expressing major histocompatibility complex (MHC) class II, enhancing the leptin-induced secretion of interferon-g (IFN-g) by CD4
+ T cells [23] . Moreover, transfer of CD4 + T cells (but not CD8 + T cells) can reverse weight gain and insulin resistance in diet-induced obese, lymphocyte-free animals [24] . Indeed, it has been demonstrated that in mice on a HFD, the number of pro-inflammatory IFNg-secreting CD4
+ T helper type 1 (Th1) cells is increased and induce inflammation as they become a more dominant force than Th2 (CD4 + GATA-binding protein-3 (GATA-3) + ) and regulatory (Foxp3) + T cells (Tregs). The role of Th1 T cells in insulin resistance has been highlighted, with mice deficient in the Th1 differentiation factor, T-bet, demonstrating altered Th1 T cell differentiation and therefore a reduction in their Th1 T cell number. These mice are also obese compared to WT controls, but do not develop insulin resistance following HFD feeding [25] . In addition, T-bet deficiency promotes Treg infiltration in the adipose tissue, contributing to the improved insulin sensitivity of this model.
Lean adipose tissue is enriched with Tregs, suggesting they may play a metabolic role [26] . Insulin can affect Treg function by inhibiting their IL-10 expression [27 ] . The type of Tregs infiltrating the adipose tissue is important to the metabolic response observed. For example, age-associated insulin resistance appears to be distinct from obesity-induced insulin resistance as adipose tissue resident Tregs (AT-Tregs) accumulate with aging but not with obesity [28] . AT-Tregs have a distinct signature compared to splenic Tregs: peroxisome proliferatoractivated receptor gamma (PPAR-g), the 'masterregulator' of adipocyte differentiation, has been shown to be important in the accumulation and phenotype of AT-Tregs [29] . Moreover, obesity affects the posttranslational modification (phosphorylation of the Ser273) of PPAR-g, mediating AT-Treg functions [30] . This accumulation of PPAR-g expressing Tregs in the adipose tissue is driven by AT-resident macrophages, which induce their differentiation and proliferation [31] . Recently, in addition to PPAR-g, the ST2 chain of the IL-33 receptor has been described as highly expressed on AT-Tregs, making them responsive to IL-33. Indeed, the reduced numbers of AT-Tregs observed in obesity can be restored with peripheral IL-33 treatment [32 ,33] .
During the development of obesity, the accumulation of B cells in the adipose tissue has also been described. These B cells promote the development of insulin resistance by producing pathogenic IgG antibodies and activating pro-inflammatory macrophages (M1) and T cells [34] . The recruitment of the B2 B cell subset is mediated by the chemokine leukotriene B4, a lipid signalling molecule increased during inflammation [35] . In contrast to B2 B cells, regulatory B cells (Bregs), which constitutively secrete IL-10, restrain adipose tissue inflammation, mirroring the function of Tregs [36] .
Recent studies have uncovered role for the innate lymphoid cells (ILCs) in obesity. ILCs, the main function of which is to protect epithelial barriers against pathogens, belong to the lymphoid lineage and are defined by absence of antigen specific B or T cell receptors [37] . The type 1 ILC subset plays a role in metabolic disease, secreting IFN-g and driving pro-inflammatory macrophage polarization to promote obesity-associated insulin resistance [38] . Another member of this group, the NK cells, are increased and activated in the adipose tissue from HFD-fed mice, promoting insulin resistance by increasing IFN-g and TNF-a production and recruiting M1 macrophages [39 ,40] . In contrast, the subset of type 2 ILC (ILC2) has been showed to improve glucose tolerance and to reduce adipose tissue inflammation though IL-13 production [41] .
In summary, the balance between the different population of pro-inflammatory (Th1, B2 B cells and ILC1) and anti-inflammatory (Tregs, Bregs and ILC2) immune cells in the adipose tissue is important to prevent increased infiltration of resident M2 macrophages and conversion of these cells into inflammatory M1 type macrophages in the adipose tissue, and thus the subsequent inflammation leading to the development of insulin resistance in the context of obesity.
Cytokines and adipocytes
Changes in adipose tissue immune status affect its cytokine content and consequently adipocyte metabolism and insulin sensitivity.
Insulin resistance
The inhibitory effect of TNF-a on insulin signalling and adipocyte differentiation has been extensively studied [42] , as has the effect of IFN-g on adipocyte metabolic function [43] . These factors interfere with the insulin receptor signalling pathway in adipocytes and promote the development of insulin resistance by inhibiting the transcription of the insulin receptor substrate 1 (IRS-1), insulin-stimulated glucose transporter 4 (GLUT-4), and PPAR-g [44] [45] [46] . IL-6, secreted by T cells and macrophages, has also been shown to affect insulin sensitivity in adipocytes through similar mechanisms to TNF-a [47] , though this deleterious effect can be ameliorated by the stimulatory effects of IL-6 on intestinal glucagon-like peptide 1 (GLP-1) secretion, which results in enhanced insulin secretion [48] .
IL-10, which is secreted by multiple anti-inflammatory immune cells, promotes insulin signalling in adipocytes via its ability to directly repress their synthesis of inflammatory cytokines like TNF-a [49] . However, IL-10 deficiency in the hematopoietic system does not potentiate adipose tissue inflammation or insulin resistance in mice on a HFD, suggesting it may not play a protective role in obesity, or that other mechanisms involved can compensate for its absence [50] . The modulation of adipocytes' insulin sensitivity may therefore not be the only mechanism that can offer potential therapeutic targets to counteract adipose tissue inflammation.
Beige adipocytes and adipogenesis
White and brown adipocytes are the two major different types of adipocyte. The primary role of white adipocytes is in energy storage, whereas brown adipocytes are involved in regulating energy expenditure and facultative thermogenesis. However, white adipocytes can acquire the morphological and functional properties of brown adipocytes by a process called 'beiging'. Beige adipocytes originate from myogenic factor 5 negative (Myf5 À ) precursors of white fat tissue and white adipocytes can become beige adipocytes (expressing uncoupling protein 1, UCP1) following stimulation by cold or b-adrenergic stimulation [51] . In the context of obesity, inflammation is associated with a reduction in the generation of beige adipocytes, which reduces adipose tissue insulin sensitivity. Locally secreted cytokines are important influences on this process.
IL-17 producing T cells represent only a small population of the immune cells that infiltrate the adipose tissue (less than 10% of the T cells). Fatty acids, which increase with obesity, regulate the expression of RAR-related orphan receptor gamma t (RORgt), which in turn regulates the differentiation of naïve CD4 + T cells into IL-17T cells through acetyl Co-A carboxylase 1, sustaining the local inflammation [52] . Indeed, IL-17 has been shown to inhibit adipocyte differentiation and glucose uptake [53] as well as the differentiation of mesenchymal stem cells into adipocytes [54] .
In contrast, IL-33 can promote the growth of beige adipocytes by accumulation and activation of ILC2s in an IL-4/13-dependent manner [55] . Another study suggests that IL-33 directly modulates the expression of uncoupling protein 1 (UCP-1) in brown and beige adipocytes, without influencing their differentiation or accumulation, and that this effect does not require on the involvement of ILC2s [56 ] .
Given this evidence, converting white adipocytes to beige adipocytes by specific patterns of cytokine signalling represents an appealing strategy to tackle the inflammation of the adipose tissue in obesity.
Conclusion
Over the last decade, our understanding of the roles of adipose tissue and its microenvironment has increased greatly. In addition to its energy storage role and the secretion of adipocytokines to regulate energy metabolism, convincing evidence has revealed the role of adipose tissue in immune function to balance the effect of systemic inflammation. The role of the immune system in the development of inflammation in the context of obesity highlights the tight balance between pro-inflammatory and anti-inflammatory signals that directly affect the metabolism of adipocytes (Figure 1) . Indeed, an elegant recent study emphasizes the role of inflammation in the stimulation of adipogenesis and how it is regulated by gut microbiota composition [57] . At present, despite the efforts made to dissect the different cellular cross talk present within the adipose tissue, it is difficult to identify the initiating event(s) in the development of adipose tissue inflammation, though it appears likely to represent both a metabolic and an immune process. However, our understanding is growing, and new strategies promoting anti-inflammatory cells as well as improving adipocyte metabolism are suggesting potential new therapeutic treatments for obesity.
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The Despite weight loss, which can improve adipose tissue inflammation and restore normal insulin sensitivity, different cytokines like interleukin-33 (IL-33), IL-4 or IL-13 can convert white adipocytes to beige adipocytes (c). This pool of beige adipocytes is able to burn lipids and may act to restore normal insulin sensitivity by reducing the pro-inflammatory environment.
